Cabot Co. (NYSE:CBT) Shares Bought by Sei Investments Co.

Sei Investments Co. lifted its stake in Cabot Co. (NYSE:CBT - Free Report) by 6.0% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 942,273 shares of the specialty chemicals company's stock after buying an additional 53,090 shares during the quarter. Sei Investments Co. owned approximately 1.74% of Cabot worth $86,039,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of CBT. American Century Companies Inc. boosted its position in Cabot by 8.5% in the 4th quarter. American Century Companies Inc. now owns 1,323,347 shares of the specialty chemicals company's stock worth $120,835,000 after purchasing an additional 103,380 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of Cabot by 1.8% during the 3rd quarter. Geode Capital Management LLC now owns 1,283,686 shares of the specialty chemicals company's stock worth $143,504,000 after acquiring an additional 22,719 shares in the last quarter. Copeland Capital Management LLC grew its holdings in Cabot by 21.6% in the fourth quarter. Copeland Capital Management LLC now owns 761,372 shares of the specialty chemicals company's stock valued at $69,521,000 after purchasing an additional 135,119 shares during the period. Charles Schwab Investment Management Inc. increased its holdings in Cabot by 0.4% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 710,608 shares of the specialty chemicals company's stock worth $64,886,000 after acquiring an additional 3,175 shares in the last quarter. Finally, JPMorgan Chase & Co. increased its stake in shares of Cabot by 13.2% during the third quarter. JPMorgan Chase & Co. now owns 355,334 shares of the specialty chemicals company's stock worth $39,716,000 after purchasing an additional 41,554 shares in the last quarter. 93.18% of the stock is owned by institutional investors and hedge funds.

Remove Ads

Cabot Stock Up 0.7 %

Shares of NYSE CBT traded up $0.57 during midday trading on Thursday, hitting $84.14. 310,367 shares of the company's stock were exchanged, compared to its average volume of 351,302. The company has a market cap of $4.56 billion, a PE ratio of 11.17, a P/E/G ratio of 0.74 and a beta of 1.21. The company has a debt-to-equity ratio of 0.72, a current ratio of 2.00 and a quick ratio of 1.29. Cabot Co. has a twelve month low of $79.57 and a twelve month high of $117.46. The firm's fifty day simple moving average is $86.02 and its 200-day simple moving average is $98.41.

Cabot (NYSE:CBT - Get Free Report) last posted its earnings results on Monday, February 3rd. The specialty chemicals company reported $1.76 EPS for the quarter, topping analysts' consensus estimates of $1.74 by $0.02. Cabot had a return on equity of 26.79% and a net margin of 10.60%. Research analysts predict that Cabot Co. will post 7.57 EPS for the current fiscal year.

Cabot announced that its board has approved a share repurchase plan on Tuesday, December 3rd that allows the company to repurchase 10,000,000 shares. This repurchase authorization allows the specialty chemicals company to buy shares of its stock through open market purchases. Shares repurchase plans are typically an indication that the company's board believes its shares are undervalued.

Cabot Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Friday, February 28th were issued a dividend of $0.43 per share. This represents a $1.72 dividend on an annualized basis and a yield of 2.04%. The ex-dividend date of this dividend was Friday, February 28th. Cabot's dividend payout ratio is presently 22.84%.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on the company. StockNews.com cut Cabot from a "buy" rating to a "hold" rating in a report on Tuesday, March 11th. Mizuho decreased their target price on shares of Cabot from $122.00 to $110.00 and set an "outperform" rating on the stock in a report on Tuesday, January 7th. Finally, JPMorgan Chase & Co. cut their price objective on Cabot from $105.00 to $85.00 and set an "underweight" rating for the company in a research report on Friday, February 21st. One research analyst has rated the stock with a sell rating, three have given a hold rating and one has issued a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of $97.00.

Cabot Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.